|
||||
|
# Liernuo Capsules are one of the CMS self-owned products, imported from
SunPharma GmbH, Germany, repackaged by Kangzhe (Hunan) Medical Co., Ltd.
and marketed by Shenzhen Kangzhe Pharmaceutical Co., Ltd. |
||||
|
|
# Liernuo
Capsules are off-patent generic pharmaceuticals targeted at the treatment
of microbial infections, such as rickettsia disease, mycoplasma/chlamydia
infection and nongonococcal urethritis. The active ingredient is antibiotic
doxycycline hyclate. # CMS is the exclusive distribution agent of this product in the PRC, and has already obtained the right to repackaging the product under the permits granted by SFDA. It is expected that the product will be launched in the coming months. |
|||
|
||||